01—History
Revenue History
Year-over-year comparison from 10-K annual reports · Dashed line: constant growth FY2020–FY2025. Drag across the bars to change the range.
- $502.1M
2 older moves run past ±150% (largest +2285.3%); point at, tap or drag across the bars to read one.
02—Ledger
03—Questions
What is revenue?
Revenue can be defined as the amount of money a company receives from its customers in exchange for the sales of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
What is BridgeBio Pharma's current revenue?
BridgeBio Pharma (BBIO) annual revenue for 2025 was $502.1M, a 126.26% increase from 2024. BridgeBio Pharma revenue for the quarter ending September 30, 2026 was $353.2M.
What was BridgeBio Pharma's revenue in 2024?
BridgeBio Pharma annual revenue for 2024 was $221.9M, a 2285.27% increase from 2023.
What was BridgeBio Pharma's revenue in 2023?
BridgeBio Pharma annual revenue for 2023 was $9.3M, a 88.02% decline from 2022.
What is BridgeBio Pharma's 5-year revenue CAGR?
BridgeBio Pharma revenue grew at a compound annual growth rate (CAGR) of 127.44% from FY2020 to FY2025, going from $8.2M to $502.1M over 5 years.
- Company
- BridgeBio Pharma
- Ticker
- BBIO
- Sector
- Healthcare
- Industry
- Pharmaceutical Preparations